Skip to main content
Premium Trial:

Request an Annual Quote

Merrill Lynch Creates BBH, Biotech Industry Security

Premium

NEW YORK--Merrill Lynch last month announced the launch of Biotech Holdrs, a new security representing 20 varied biotechnology companies, including several genomics companies. The price of the security was $109.18 each when trading began November 23 on the American Stock Exchange under the symbol BBH. 4.5 million Holdrs, representing undivided beneficial ownership interest in the common stock, were initially priced at a total of more than $490 million.

The company said it selected 20 of the largest and most liquid companies in the biotechnology industry, measured by market capitalization and trading volume. The security includes 46 shares of Amgen, 9 of PE Biosystems, 3 of Millennium Pharmaceuticals, and 2 shares each of Affymetrix, Celera, and Human Genome Sciences. Dow Jones Newswires reported that a purchase would likely require a minimum $10,000 investment.

Filed under

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.